Martina Kluibenschaedl, Mag.
UMIT - University for Health Sciences, Medical Informatics and Technology, Institute of Public Health, Medical Decision Making and HTA, Department of Public Health and HTA
Eduard-Wallnoefer-Center 1
Hall in Tyrol
Austria
6060
Papers:
COST-EFFECTIVENESS OF THE SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA PATIENTS IN THE UNITED STATES
Student?
yes
SMDM Member?
yes